Gilead Sciences (GILD) Cash from Investing Activities (2009 - 2026)

Gilead Sciences (GILD) has reported Cash from Investing Activities for 18 consecutive years, with -$10.3 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Investing Activities fell 388.99% year-over-year to -$10.3 billion; the trailing twelve-month figure through Jun 2026 stood at -$10.8 billion (down 212.72% YoY), and the FY2025 full-year result was -$4.8 billion, down 38.97% from the prior year.
• Cash from Investing Activities slipped to -$10.3 billion in Q2 2026 per GILD's latest filing, from $1.8 billion in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $1.8 billion in Q1 2026 and bottomed at -$10.3 billion in Q2 2026.
• Historically, Cash from Investing Activities has averaged -$1.2 billion across 5 years, with a median of -$596.5 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities tumbled 715.56% in 2025, then soared 526.51% in 2026.
• Over 5 years, Cash from Investing Activities stood at -$375.0 million in 2022, then sank by 93.87% to -$727.0 million in 2023, then surged by 69.05% to -$225.0 million in 2024, then sank by 715.56% to -$1.8 billion in 2025, then tumbled by 463.87% to -$10.3 billion in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$10.3 billion, $1.8 billion, and -$1.8 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.